healthcare-thumbnail.png

Chemotherapy Induced Pain (CIP) Market Research Report

Published: 2025 - January

Report Code: VMR-17744

Region: Global

Request Sample
Customization
Ask an Expert
Enquire Enquire Before Buying

Chemotherapy Induced Pain (CIP) Market Analysis

The Chemotherapy Induced Pain (CIP) Market focuses on addressing the significant pain-related side effects that cancer patients experience during or after chemotherapy. This pain arises from nerve damage, inflammation, or other factors associated with chemotherapy agents. The market encompasses a range of therapeutic options, including emerging and established drugs designed to alleviate or prevent neuropathic, somatic, or mixed pain types.

Disruptive Impact and Opportunities:

Emerging solutions targeting unmet needs, such as neuropathic pain caused by platinum-based chemotherapy, are entering the pipeline. Simplified delivery mechanisms like intrathecal pumps and patches ensure ease of use for patients. Safer profiles with fewer side effects are becoming a focus, driving better patient adherence. Scalability with the growing global cancer burden provides a vast addressable market.

Chemotherapy Induced Pain (CIP) Market Segmentation: Emerging Drugs

  • Halneuron

  • MP-101

  • NRD.E1

Chemotherapy Induced Pain (CIP) Market Segmentation: Marketed Drugs

  • Cisplatin

  • Carboplatin

  • Oxaliplatin

  • Paclitaxel

  • Docetaxel

Key Companies:

  • WEX Pharmaceuticals

  • NOVAREMED AG

  • Regenacy Pharmaceuticals

  • Eli Lilly

  • Gilead Sciences, Inc.

  • Solasia Pharma K.K.

Chemotherapy Induced Pain (CIP) Market Segmentation: By Type

  • Neuropathic Pain

    • Chemotherapy-induced peripheral neuropathy (CIPN)

    • Central neuropathic pain

  • Somatic Pain

    • Musculoskeletal pain

    • Joint pain

    • Bone pain

  • Visceral Pain

    • Abdominal pain

    • Organ pain

  • Mixed Pain

    • Combination of somatic and neuropathic pain

Chemotherapy Induced Pain (CIP) Market Segmentation: By Administration Type

  • Oral Administration

    • Tablets

    • Capsules

    • Liquid formulations

  • Injectable Administration

    • Subcutaneous injections

    • Intravenous injections

  • Topical Administration

    • Creams

    • Gels

    • Patches

  • Intrathecal/ Epidural Administration

    • Intrathecal pumps

    • Epidural injections

What’s in It for You?

  • Emerging therapies and their potential for market disruption.

  • Pipeline analysis to identify investment opportunities.

  • Competitive landscape with detailed profiles of key players.

  • Trends shaping the future of pain management in oncology.

  • Comprehensive segmentation to identify high-growth areas.

  1. Chemotherapy Induced Pain Market - Executive Summary

    1. Introduction

    2. Objectives

    3. Key Findings

      1. Market Size 2025 & 2030: By Key Country (10MM)

      2. Global Market Size 2025 & 2030: By Key Segment

      3. Key Investments & Startup Analysis

    4. Research Methodology

  2. Understanding the Disease

    1. Disease Overview

    2. Classification

    3. Signs and Symptoms

    4. Risk Factors

    5. Causes

    6. Disease Biology & Digital Innovations

    7. Stages & Staging System

    8. Diagnostic Algorithm

    9. Current Treatment Practices & Algorithm

    10. Current Standard of Care and Treatment Gaps

    11. Patient Demographics and Treatment Pathways

  3. Guidelines

  4. Unmet Needs

  5. Epidemiology and Patient Population

    1. Epidemiology Key Findings

    2. Assumptions and Rationale: 10MM

    3. Epidemiology Scenario: 10MM

    4. U.S. Epidemiology Scenario

    5. EU-5 Epidemiology

      1. U.K. Epidemiology Scenario

      2. Germany Epidemiology Scenario

      3. France Epidemiology Scenario

      4. Italy Epidemiology Scenario

      5. Spain Epidemiology Scenario

    6. Japan Epidemiology Scenario

    7. China Epidemiology Scenario

    8. Australia Epidemiology Scenario

    9. India Epidemiology Scenario   

  6. Real-world Data & Real-world Evidence

  7. Drug Development Landscape

    1. Existing Key Drug Candidate Profiles/ Marketed Therapies

    2. Competitive Analysis and Differentiation

    3. Overview of Similar/Competing Drugs in Clinical Trials

    4. Future Trends and Emerging Drugs

  8. Regulatory Strategy and Potential Challenges

    1. Regulatory Pathways in Key Markets

    2. Anticipated Regulatory Hurdles and Mitigation Strategies

    3. Case Studies in Oncology Drug Regulation

    4. Impact of Potential Changes to Regulatory Framework

  9. Commercial Landscape

    1. Market Size & Growth Rates

    2. Key Approvals & Anticipated Loss of Exclusivity

    3. PESTLE & Porter’s Five Forces Analysis

    4. Market Shares, Positioning/Ranking

    5. Market Drivers

    6. Identification of Threats

    7. Digital Evolution in Commercialization

  10. Market Segmentation

  11. Pricing, Reimbursement, and Access

    1. Competitive Pricing Analysis

    2. Reimbursement Landscape and Challenges

    3. Strategies for Market Access and Equity

    4. Patient Spending/Expenditure Analysis

  12. Future Trends, Disruptions, and Opportunities

    1. Analysis of Emerging Trends

    2. Technological Impact

    3. Impact of Potential Market Disruptors

    4. Opportunities for Future Development and Expansion

    5. Considerations for Investment Opportunities

  13. Global Market Dynamics

    1. Regional Regulatory Disparities

    2. Cross-Border Partnership Strategies

    3. Global Supply Chain Dynamics

    4. Case Studies: Success and Failure in Global Markets

    5. Strategies for Global Expansion and Localization

  14. Company Profiles

 

 

Download Sample

↻

The field with (*) is required.

Choose License Type

$

2500

$

4250

$

5250

$

6900

Request Sample
Customization
Ask an Expert
Enquire Before Buying
customer-support

Analyst Support

Every order comes with Analyst Support.

report-custom

Customization

We offer customization to cater your needs to fullest.

verify

Verified Analysis

We value integrity, quality and authenticity the most.

© 2025 Virtue Market Research. All Rights Reserved.